| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.009 |